Medical Dictionary (Jpn-Eng)

5
Medical Dictionary (Jpn-Eng) is an Android app from 日中韓辭典研究所 in the Books & Reference category, currently rated — across few ratings. Initial signal reads as largely positive sentiment, users highlighting consistency and feature depth.
Quality Score is 5: Niche (micro-niche or pre-traction stage). For a Books & Reference app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Books & Reference complexity ×0.95 | $-2525 |
| 🌐 Cross-platform reach (iOS + Android) | +$26K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| 🏷 Books & Reference category multiple | -2% |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 🏷 Category context | Books & Reference |
| 📦 Compact Android bundle | → Native Kotlin |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Pre-traction · 37/100INDIE TIERlimited signal- 💰 Revenue: Modest — $663 - $4146/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- Medical Dictionary (Jpn-Eng)
- Developer
- 日中韓辭典研究所
- Bundle ID
- org.cjki.jetec.med
- App Store URL
- Open in App Store
- Category
- Books & Reference
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.cjk.org
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $115/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
Do you know how to say "type V acrocephalosyndactyly" in Japanese? With this application you can immediately find the equivalent of V型尖頭合指症.
At home, at work and on the go, translators, students and professionals of medicine and life sciences will often encounter technical terms related to pharmaceutics, dentistry, biotechnology and the like for which they need to quickly look up their Japanese or English translations.… View full description on the official store →
Tech & Domain Intel — cjk.org
- Tech stack
- Google Workspace
Track this app’s revenue
FREE📝 Description
95
More by 日中韓辭典研究所
View all →Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
Medical Dictionary (Jpn-Eng) is a very early-stage Android app in the books & reference space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




